Left atrial intramural hematoma after percutaneous coronary intervention
Related Experiment Video
Updated: Oct 23, 2025
12:03
Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
28.2K
Jun Takaki1, Takashi Yoshinaga1, Kosaku Nishigawa1
1Department of Cardiovascular Surgery Kumamoto University Hospital Kumamoto Japan.
Clinical Case Reports
|August 25, 2021
Insights
Left atrial intramural hematoma, a rare complication of percutaneous coronary intervention, can be treated with a combination of surgical and interventional therapies.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Percutaneous coronary intervention (PCI) is a common procedure for treating coronary artery disease.
- Complications of PCI, though rare, require specific management strategies.
- Left atrial intramural hematoma (LAIH) is an uncommon but serious complication.
Observation:
- This abstract discusses a rare case of left atrial intramural hematoma.
- The hematoma developed as a complication following a percutaneous coronary intervention procedure.
- The case highlights the need for awareness of this specific complication.
Findings:
- Left atrial intramural hematoma is a rare complication associated with percutaneous coronary intervention.
- The study suggests that a combined therapeutic approach, integrating both surgical and interventional methods, is a viable treatment option for LAIH.
Implications:
- This information is crucial for cardiologists and cardiac surgeons managing patients post-PCI.
- The findings support the consideration of combined surgical and interventional strategies for rare complications like LAIH.
- Further research may elucidate optimal treatment algorithms for left atrial intramural hematoma.
Abstract:
Left atrial intramural hematoma is a rare complication of percutaneous coronary intervention. The combination treatment with surgery and interventional therapy is one of therapeutic options.
